JNCI_Now Profile Banner
JNCI Profile
JNCI

@JNCI_Now

Followers
25K
Following
2K
Media
3K
Statuses
12K

Publishing impactful cancer research with a global mission, the JNCI family of journals champion quality, innovation, and equity.

Joined April 2009
Don't wanna be here? Send us removal request.
@JNCI_Now
JNCI
2 years
📢 Calling Early Career Investigators!. Is publishing your research with a respected journal on your 2024 #Resolutions list? . You're in luck - @JNCI_Now is creating a special section devoted to publishing manuscripts from ECIs. Find out more here:
Tweet media one
6
8
18
@JNCI_Now
JNCI
8 hours
Using a 313-variant polygenic risk score (PRS), we propose risk-adapted breast cancer screening starting ages instead of a universal shift to 40 (Figure 1).
0
0
0
@JNCI_Now
JNCI
1 day
Reviewing a decade of records, South and East African men are at 3-fold greater risk for prostate cancer death than both White and Black Americans, while within Sub-Saharan Africa the impact of this disease appears to be under-estimated for East Africa.
0
0
2
@JNCI_Now
JNCI
2 days
Using a novel, hierarchical approach to ask questions about reasons for a mammogram, article authors showed self-reported reasons for mammography had good agreement with electronic health record data. @kpwaresearch
0
1
1
@JNCI_Now
JNCI
3 days
Mammographic classification of interval breast cancers reveals potential for AI to improve cancer detection at time of screening in the U.S.
0
0
0
@JNCI_Now
JNCI
5 days
This systematic review and meta-analysis found that radiation, chemotherapy, and their combination were associated with an increased risk of secondary malignancies after treatment of testicular germ cell tumors, while surgery alone was not. @moosemousa
0
1
4
@JNCI_Now
JNCI
6 days
A recent study by the American Cancer Society found that following the American Cancer Society Guideline for Cancer Survivors after diagnosis is linked to lower mortality risk among non-smoking survivors of obesity-related cancers.
0
0
0
@JNCI_Now
JNCI
7 days
DFCI, MDACC, SGK, IBC Research Foundation + the Milburn Foundation validate a new IBC web tool that helps providers accurately diagnose inflammatory breast cancer so patients don't miss out on rapid, guideline concordant care. @ibcradiation @mdandersonnews
0
0
0
@JNCI_Now
JNCI
8 days
Asian American, Pacific Islander and White solid organ transplant recipients have higher risk of multiple cancers compared w/ their race-matched general population. Risk difference could vary due to transplantation or other factors. @theNCI @TaoJunRose
0
1
1
@JNCI_Now
JNCI
9 days
📢 Exciting opportunity! The JNCI family of journals are recruiting a Social Media Editor. Join us in advancing cancer research visibility and engagement online. Apply now:
Tweet media one
0
0
0
@JNCI_Now
JNCI
9 days
Exercise training, especially combined RT + AT, can potentially reduce pro-inflammatory biomarkers in survivors of breast cancer. Considering association between inflammation and tumor progression, exercise should be routinely integrated. @Fbettariga
0
2
4
@JNCI_Now
JNCI
10 days
hrHPV type-specific CIN2/CIN3/AIS population-based incidence decreased significantly for vaccine types HPV16/18 and for HPV31 and HPV33. However, the LT vaccine impact in cohorts receiving the 4-valent vaccine requires continued follow-up. @UNMCCC
0
0
0
@JNCI_Now
JNCI
10 days
Are you an early-career oncology researcher? Enhance your editorial experience with the JNCI Mentorship Program! Join virtual discussions, learn from workshops, and shadow editorial leaders. Applications close June 30, 2025. 🔗Learn more & apply:
Tweet media one
0
0
2
@JNCI_Now
JNCI
12 days
A @PennCancer team has defined a network of tumor-intrinsic and immune-related molecular traits that distinguish the subset of early stage HPV+ oropharyngeal cancers predisposed to fail standard therapy:. @basulab1 @PennMedicine @Penn_ENT @Penn_CBIO.
0
2
11
@JNCI_Now
JNCI
13 days
Neighborhood disadvantage associated with higher cancer risk behaviors among African Americans - Multi-level approaches to improve health equity will be required.
0
0
0
@JNCI_Now
JNCI
14 days
🎓Calling all early-career oncology researchers! Apply for the @JNCI_Now Editorial Mentorship Program and take your next step towards becoming a peer reviewer. Deadline: June 30, 2025. 🔗Learn more & apply:
Tweet media one
0
0
0
@JNCI_Now
JNCI
15 days
Recent clinical trial results in TNBC lacked strong evidence to support using pCR as a surrogate marker for LT survival in early-stage TNBC patients at trial level. LT efficacy+safety of minimising drug approval delay must be assessed.@TYoshiMD @TFujii_MD
0
0
1
@JNCI_Now
JNCI
17 days
After adjusting for treatment selection bias, RCT overall survival and RCT radiographic progression-free survival estimates serve as useful, or even conservative, predictors of real-world overall survival gain.
0
1
2
@JNCI_Now
JNCI
19 days
According to many recent reports, colon cancer is increasing in the young. However, most of the increase can now be attributed to the reclassification of appendix NET/carcinoids. Recommendations for colon cancer screening at an earlier age may be affected.
0
1
1
@JNCI_Now
JNCI
20 days
Dynamic weight measurements in medical records of patients with advanced cancer enable early identification of those who go on to experience progressive weight loss and shorter survival. @KPCancerRsrch
0
0
0
@JNCI_Now
JNCI
21 days
LLMs show promise in supporting patient-friendly clinical trial educational materials, but human oversight is still needed @dbittermanmd.
Tweet media one
0
0
0